Company Filing History:
2 out of 3,100 
1 out of 1 Years Active: 2014
Title: Xuemei Zhang: Innovator in Antidepressant Research
Introduction
Xuemei Zhang is a notable inventor based in Kunming, China. She has made significant contributions to the field of medicine, particularly in the development of treatments for depression. Her innovative work has led to the filing of a patent that showcases her research and findings.
Latest Patents
Xuemei Zhang holds a patent titled "Application of 5-methyl-1,3-benzenediol or derivatives thereof in the preparation of medicines and functional foods for treatment or prevention of depression." This invention relates to the application of 5-methyl-1,3-benzenediol or its derivatives, which have been shown to exhibit more significant antidepressant effects than traditional medications such as fluoxetine or imipramine. The patent emphasizes the potential of these compounds in creating effective pharmaceutical compositions for treating depression.
Career Highlights
Throughout her career, Xuemei Zhang has worked with esteemed institutions, including the Chinese Academy of Sciences and Kunming Jingbiao Biosciences R&D Co., Ltd. Her research has focused on the development of functional foods and medicines aimed at improving mental health.
Collaborations
Xuemei Zhang has collaborated with notable colleagues, including Jijun Chen and Lin Xu. These partnerships have contributed to her research and the advancement of her innovative ideas in the field of antidepressant treatments.
Conclusion
Xuemei Zhang's work in the application of 5-methyl-1,3-benzenediol represents a significant advancement in the treatment of depression. Her contributions to medicine and her innovative spirit continue to inspire future research in this vital area.